Skip to content
healthcare.dev

Tizanidine Hydrochloride

NDC 73352-089, tizanidine hydrochloride, capsule, from Trifluent Pharma, LLC.

Product NDC
73352-089
Status
Listed
Labeler
Trifluent Pharma, LLC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213798
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73352-089 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIZANIDINE HYDROCHLORIDE8 mg/1

Pharmacologic classes

Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
73352-089-607335200896060 CAPSULE in 1 BOTTLE (73352-089-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4a2cf456-58c5-c26d-e063-6294a90a0b24

Use it

Look up 73352-089 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73352-089 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73352-089. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.